ArticleEBioMedicine2022

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial.

Camilla Huse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.